PREVALENCE AND RISK FACTORS ASSOCIATED WITH VIRAL HEPATITIS B AND C AMONG IMMUNOCOMPROMISED PATIENTS Case study: Kibuye Referral Hospital
| dc.contributor.author | KAMANYANA, Drocelle | |
| dc.contributor.author | MUKESHIMANA, James | |
| dc.date.accessioned | 2023-10-30T11:05:33Z | |
| dc.date.available | 2023-10-30T11:05:33Z | |
| dc.date.issued | 2023-08 | |
| dc.description | 1.0 INTRODUCTION This chapter one is concerned with the background of the study, problem statement, purpose of the study, objective of the study, research question, significance of the study, limitation of the study, and scope of the study about the prevalence of viral hepatitis B and C among immunocompromised patients. | en_US |
| dc.description.abstract | Globally hepatitis B virus (HBV) is enormous, with 257 million people chronically infected each year and over 880,000 deaths worldwide. In sub-Saharan Africa where is belonging Rwanda, approximately 60 million people are chronically infected with the hepatitis B virus (HBV) and 10. 2 million people chronically infected with hepatitis C virus (HCV). | en_US |
| dc.description.sponsorship | HITAYEZU Elysée | en_US |
| dc.identifier.citation | APA | en_US |
| dc.identifier.uri | https://repository.kp.ac.rw/xmlui/handle/123456789/175 | |
| dc.language.iso | en | en_US |
| dc.publisher | Kibogora Polytechnic | en_US |
| dc.subject | VIRAL HEPATITIS B | en_US |
| dc.subject | IMMUNOCOMPROMISED PATIENTS | en_US |
| dc.title | PREVALENCE AND RISK FACTORS ASSOCIATED WITH VIRAL HEPATITIS B AND C AMONG IMMUNOCOMPROMISED PATIENTS Case study: Kibuye Referral Hospital | en_US |
| dc.type | Thesis | en_US |